The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas
Abstract
The development of an artificial pancreas is placed in the context of the history of the field of feedback control systems, beginning with the water clock of ancient Greece, and including a discussion of current efforts in the control of complex systems. The first generation of artificial pancreas devices included two manipulated variables (insulin and glucose infusion) and nonlinear functions of the error (difference between desired and measured glucose concentration) to minimize hyperglycemia while avoiding hypoglycemia. Dynamic lags between insulin infusion and glucose measurement were relatively small for these intravenous-based systems. Advances in continuous glucose sensing, fast-acting insulin analogs, and a mature insulin pump market bring us close to commercial realization of a closed-loop artificial pancreas. Model predictive control is discussed in-depth as an approach that is well suited for a closed-loop artificial pancreas. A major challenge that remains is handling an unknown glucose disturbance (meal), and an approach is proposed to base a current insulin infusion action on the predicted effect of a meal on future glucose values. Better "meal models" are needed, as a limited knowledge of the effect of a meal on the future glucose values limits the performance of any control algorithm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Optimum Settings for Automatic Controllers
Ziegler, J. G., & Nichols, N. B. (1942) · Journal of Fluids Engineering · doi:10.1115/1.4019264 · Cited by 5,212
Optimum Settings for Automatic Controllers
Ziegler, J. G., & Nichols, N. B. (1993) · Journal of Dynamic Systems Measurement and Control · doi:10.1115/1.2899060 · Cited by 2,460
Optimal Control and Estimation
Stengel, R. F. (1994) · Cited by 1,617
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
Hovorka, R., Canonico, V., Chassin, L. J., Haueter, U., Massi-Benedetti, M., Federici, M. O., Pieber, T. R., Schaller, H. C., Schaupp, L., Vering, T., et al. (2004) · Physiological Measurement · doi:10.1088/0967-3334/25/4/010 · Cited by 1,274
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Levine, W. S. (2005) · Cited by 1,064
Nonlinear control of chemical processes: a review
Bequette, B. W. (1991) · Industrial & Engineering Chemistry Research · doi:10.1021/ie00055a001 · Cited by 566
Self-citationFeasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
Steil, G. M., Rebrin, K., Darwin, C., Hariri, F., & Saad, M. F. (2006) · Diabetes · doi:10.2337/db06-0419 · Cited by 473
Disturbance modeling for offset-free linear model predictive control
Muske, K. R., & Badgwell, T. A. (2002) · Journal of Process Control · doi:10.1016/s0959-1524(01)00051-8 · Cited by 464
A physiological model of glucose-insulin interaction in type 1 diabetes mellitus
Lehmann, E. D., & Deutsch, T. (1992) · Journal of Biomedical Engineering · doi:10.1016/0141-5425(92)90058-s · Cited by 401
Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT
Hovorka, R., Shojaee-Moradie, F., Carroll, P. V., Chassin, L. J., Gowrie, I. J., Jackson, N. C., Tudor, R. S., Umpleby, A. M., & Jones, R. H. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00304.2001 · Cited by 393
An Artificial Endocrine Pancreas
Albisser, A. M., Leibel, B. S., Ewart, T. G., Davidovac, Z., Botz, C. K., & Zingg, W. (1974) · Diabetes · doi:10.2337/diab.23.5.389 · Cited by 379
Future directions in control in an information-rich world
(2003) · IEEE Control Systems · doi:10.1109/mcs.2003.1188769 · Cited by 367
Development of the PID controller
Bennett, S. (1993) · IEEE Control Systems · doi:10.1109/37.248006 · Cited by 314
Closed-loop insulin delivery—the path to physiological glucose control
Steil, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.011 · Cited by 313
Application of Micro- and Nano-Electromechanical Devices to Drug Delivery
Staples, M., Daniel, K., Cima, M. J., & Langer, R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9906-4 · Cited by 311
Clinical Control of Diabetes by the Artificial Pancreas
Albisser, A. M., Leibel, B. S., Ewart, T. G., Davidovac, Z., Botz, C. K., Zingg, W., Schipper, H., & Gander, R. (1974) · Diabetes · doi:10.2337/diab.23.5.397 · Cited by 272
The intravenous route to blood glucose control
Parker, R. S., Doyle, F. J., & Peppas, N. A. (2001) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/51.897829 · Cited by 236
An Improved PID Switching Control Strategy for Type 1 Diabetes
Marchetti, G., Barolo, M., Jovanovic, L., Zisser, H., & Seborg, D. E. (2008) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2008.915665 · Cited by 212
Kanji, S., Singh, A., Tierney, M., Meggison, H., McIntyre, L., & Hebert, P. C. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2252-2 · Cited by 208
Closing the Loop: The Adicol Experience
Hovorka, R., Chassin, L. J., Wilinska, M. E., Canonico, V., Akwi, J. A., Federici, M. O., Massi‐Benedetti, M., Hutzli, I., Zaugg, C., Kaufmann, H., et al. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504774197990 · Cited by 153
Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy
Renard, É. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00216-3 · Cited by 153
Control-relevant modeling in drug delivery
Parker, R. S., & Doyle, F. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00114-4 · Cited by 120
Advances Toward the Implantable Artificial Pancreas for Treatment of Diabetes
Jaremko, J., & Rorstad, O. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.444 · Cited by 111
Hypoglycemia Prediction and Detection Using Optimal Estimation
Palerm, C. C., Willis, J. P., Desemone, J., & Bequette, B. W. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.3 · Cited by 97
Self-citationThe Extended Kalman Filter for Continuous Glucose Monitoring
Knobbe, E. J., & Buckingham, B. A. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.15 · Cited by 95
AUTOMATION CONTROL OF BLOOD SUGAR. I. A SERVOMECHANISM FOR GLUCOSE MONITORING AND CONTROL.
Kadish, A. H. (1964) · PubMed · Cited by 94
Shimoda, S., Nishida, K., Sakakida, M., Konno, Y., Ichinose, K., Uehara, M., Nowak, T., & Shichiri, M. (1997) · PubMed · Cited by 85
Modeling Insulin Action for Development of a Closed-Loop Artificial Pancreas
Steil, G. M., Clark, B., Kanderian, S. S., & Rebrin, K. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.94 · Cited by 83
Run-to-Run Control of Meal-Related Insulin Dosing
Zisser, H., Jovanovič, L., Doyle, F., Ospina, P., & Owens, C. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.48 · Cited by 79
Feedback control dynamics for glucose controlled insulin infusion system.
Clemens, A. H. (1979) · PubMed · Cited by 72
A circulatory model for combined nitroprusside-dopamine therapy in acute heart failure.
Yu, C., Roy, R., & Kaufman, H. (1990) · PubMed · Cited by 56
Numerical approximation of mathematical model for absorption of subcutaneously injected insulin
Wach, P., Trajanoski, Z., Kotanko, P., & Skrabal, F. (1995) · Medical & Biological Engineering & Computing · doi:10.1007/bf02522939 · Cited by 43
Harold Black and the negative-feedback amplifier
Kline, R. R. (1993) · IEEE Control Systems · doi:10.1109/37.229565 · Cited by 36
Kerner, W., Thum, C., jun., G. T., Beischer, W., Clemens, A. H., & Pfeiffer, E. E. (1976) · Hormone and Metabolic Research · doi:10.1055/s-0028-1093650 · Cited by 35
An Improved Control Algorithm for an Artificial B-Cell
Botz, C. K. (1976) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.1976.324639 · Cited by 33
Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop
Hanaire, H. P. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(06)72808-7 · Cited by 32
Automated insulin delivery for type 1 diabetes
Steil, G. M., & Saad, M. F. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000216971.61160.57 · Cited by 23
Novel Control System for Blood Glucose Using a Model Predictive Method
Kan, S., Onodera, H., Furutani, E., et al. (2000) · ASAIO Journal · doi:10.1097/00002480-200011000-00004 · Cited by 12
Model predictive control for optimal oral anticoagulant drug administration
Pannocchia, G., & Brambilla, A. (2006) · AIChE Journal · doi:10.1002/aic.10930 · Cited by 9
Cited by
Artificial Pancreas: Past, Present, Future
Cobelli, C., Renard, E., & Kovatchev, B. (2011) · Diabetes · doi:10.2337/db11-0654 · Cited by 600
Weinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V. (2008) · Diabetes Care · doi:10.2337/dc07-1967 · Cited by 567
Diabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511
“As observed by [243], this means that after a meal,”
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
Steil, G. M., Rebrin, K., Darwin, C., Hariri, F., & Saad, M. F. (2006) · Diabetes · doi:10.2337/db06-0419 · Cited by 473
Hovorka, R., Allen, J. M., Elleri, D., Chassin, L. J., Harris, J., Xing, D., Kollman, C., Hovorka, T., Larsen, A. M. F., Nodale, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61998-x · Cited by 450
Metadata
- Authors
- Bequette, B. W.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2005-02
- Volume
- 7
- Issue
- 1
- Pages
- 28-47
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W1991725952
- Cited by
- 270
- References
- 40
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.